Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen's Repatha gets a thumbs-down from U.K. cost-effectiveness watchdogs
Amgen's Repatha gets a thumbs-down from U.K. cost-effectiveness watchdogs
Amgen's Repatha gets a thumbs-down from U.K. cost-effectiveness watchdogs
Submitted by
admin
on November 18, 2015 - 10:15pm
Source:
Fierce Pharma
News Tags:
Amgen
Repatha
NICE
UK
PCSK9 inhibitors
Headline:
Amgen's Repatha gets a thumbs-down from U.K. cost-effectiveness watchdogs
Do Not Allow Advertisers to Use My Personal information
